BII Biocompatibles

 
TIDMBII 
 
5 January 2011 
 
                       BIOCOMPATIBLES INTERNATIONAL PLC 
 
                      (the `Company' or `Biocompatibles') 
 
             BIOCOMPATIBLES INTERNATIONAL PLC SHARE INCENTIVE PLAN 
 
         PURCHASE OF PARTNERSHIP SHARES AND AWARDS OF MATCHING SHARES 
 
Biocompatibles International plc announces that on 4 January 2011the following 
executive directors purchased ordinary shares of 21 53/94 pence at a cost of 
389.7 pence per share as "partnership shares" under the all-employee 
Biocompatibles International Share Incentive Plan as summarised below: 
 
Executive Director         Number of shares acquired 
 
Crispin Simon              32 
 
Ian Ardill                 32 
 
Peter Stratford            32 
 
John Sylvester             32 
 
The above transactions were undertaken by the trustee of the Biocompatibles 
International Share Incentive Plan, a UK registered company, on behalf of the 
above individuals and the shares purchased on the London Stock Exchange. 
 
In connection with the above purchases on the same date the executive directors 
were conditionally awarded ordinary shares of 21 53/94 pence as "matching 
shares" under the all employee Biocompatibles International Share Incentive 
Plan as summarised below: 
 
Executive Director         Number of shares awarded as "matching 
                           shares" 
 
Crispin Simon              64 
 
Ian Ardill                 64 
 
Peter Stratford            64 
 
John Sylvester             64 
 
The risk of forfeiture attached to the matching shares will normally be removed 
on the third anniversary of allocation subject to continued employment and the 
retention of the Partnership shares in connection with which they were awarded. 
 
No consideration was paid by the grantees for the award of the matching shares 
and no consideration is due on the release of on the matching shares. 
 
             BIOCOMPATIBLES INTERNATIONAL PLC SHARE INCENTIVE PLAN 
 
                     VESTING OF AWARDS OF MATCHING SHARES 
 
Biocompatibles International plc announces that on 31 December 2010 the 
following executive directors became unconditionally entitled to the following 
number of ordinary shares of 21 53/94 pence under the all-employee 
Biocompatibles International Share Incentive Plan ("SIP") as summarised below: 
 
Executive Director         Number of shares vesting under SIP 
 
Crispin Simon              204 
 
Ian Ardill                 204 
 
Peter Stratford            204 
 
John Sylvester             202 
 
The shares so vesting under awards of "matching shares" awarded under the SIP 
on 31 December 2007. 
 
No consideration was paid by the individual for the maturity of their "matching 
shares". 
 
The above notifications are made in accordance with DTR 3.1.4R(1). 
 
Biocompatibles International plc was notified by the above individuals of the 
above transactions on 04 January 2011. 
 
                                   - ends - 
 
Contact: 
Biocompatibles                             Tel: +44 (0)1257 732732 
 
Ian Ardill, Finance Director 
 
Sari Evetts, Assistant Company Secretary 
 
Dealing Disclosure Requirements 
 
Following the announcement made on Monday, 20 September 2010 that the Company 
is in an offer period for the purposes of the Takeover Code, the Company is 
required to restate the following: 
 
Under Rule 8.3(a) of the Code, any person who is interested in 1% or more of 
any class of relevant securities of an offeree company or of any paper offeror 
(being any offeror other than an offeror in respect of which it has been 
announced that its offer is, or is likely to be, solely in cash) must make an 
Opening Position Disclosure following the commencement of the offer period and, 
if later, following the announcement in which any paper offeror is first 
identified. An Opening Position Disclosure must contain details of the person's 
interests and short positions in, and rights to subscribe for, any relevant 
securities of each of (i) the offeree company and (ii) any paper offeror(s). An 
Opening Position Disclosure by a person to whom Rule 8.3(a) applies must be 
made by no later than 3.30 pm (London time) on the 10th business day following 
the commencement of the offer period and, if appropriate, by no later than 3.30 
pm (London time) on the 10th business day following the announcement in which 
any paper offeror is first identified. Relevant persons who deal in the 
relevant securities of the offeree company or of a paper offeror prior to the 
deadline for making an Opening Position Disclosure must instead make a Dealing 
Disclosure. 
 
Under Rule 8.3(b) of the Code, any person who is, or becomes, interested in 1% 
or more of any class of relevant securities of the offeree company or of any 
paper offeror must make a Dealing Disclosure if the person deals in any 
relevant securities of the offeree company or of any paper offeror. A Dealing 
Disclosure must contain details of the dealing concerned and of the person's 
interests and short positions in, and rights to subscribe for, any relevant 
securities of each of (i) the offeree company and (ii) any paper offeror, save 
to the extent that these details have previously been disclosed under Rule 8. A 
Dealing Disclosure by a person to whom Rule 8.3(b) applies must be made by no 
later than 3.30 pm (London time) on the business day following the date of the 
relevant dealing. If two or more persons act together pursuant to an agreement 
or understanding, whether formal or informal, to acquire or control an interest 
in relevant securities of an offeree company or a paper offeror, they will be 
deemed to be a single person for the purpose of Rule 8.3. 
 
Opening Position Disclosures must also be made by the offeree company and by 
any offeror and Dealing Disclosures must also be made by the offeree company, 
by any offeror and by any persons acting in concert with any of them (see Rules 
8.1, 8.2 and 8.4). 
 
Details of the offeree and offeror companies in respect of whose relevant 
securities Opening Position Disclosures and Dealing Disclosures must be made 
can be found in the Disclosure Table on the Takeover Panel's website at 
www.thetakeoverpanel.org.uk, including details of the number of relevant 
securities in issue, when the offer period commenced and when any offeror was 
first identified. If you are in any doubt as to whether you are required to 
make an Opening Position Disclosure or a Dealing Disclosure, you should contact 
the Panel's Market Surveillance Unit on +44 (0)20 7638 0129. 
 
 
 
END 
 

Biocompatibles (LSE:BII)
Historical Stock Chart
From Sep 2024 to Oct 2024

Biocompatibles (LSE:BII)
Historical Stock Chart
From Oct 2023 to Oct 2024